The role of PD-1/PD-L1 axis in idiopathic pulmonary fibrosis: Friend or foe?

Jiang, Aimin; Liu, Na; Wang, Jingjing; Zheng, Xiaoqiang; Ren, Mengdi; Zhang, Wei; Yao, Yu

Jiang, Aimin; Liu, Na; Wang, Jingjing; Zheng, Xiaoqiang; Ren, Mengdi; Zhang, Wei; Yao, Yu.

Afiliação

Jiang A; Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Liu N; Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Wang J; Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Zheng X; Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Ren M; Institute for Stem Cell & Regenerative Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Zhang W; Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Yao Y; Military Physical Education Teaching and Research Section of Air Force Medical Service Training Base, Air Force Medical University, Xi'an, China.

Front Immunol ; 13: 1022228, 2022.

Article em En | MEDLINE | ID: mdl-36544757

Assuntos

Fibrose Pulmonar Idiopática; Neoplasias Pulmonares; Animais; Camundongos; Antígeno B7-H1/metabolismo; Receptor de Morte Celular Programada 1/metabolismo

Palavras-chave

PD-1; PD-L1; idiopathic pulmonary fibrosis; immunomodulatory role; profibrotic role; therapeutic target

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrose Pulmonar Idiopática / Neoplasias Pulmonares Limite: Animals Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google